KRYS | Krystal Biotech, Inc. | 轉虧為盈% | 轉虧為盈% |
RETA | Reata Pharmaceuticals, Inc. | 11273.7% | 2885% |
PRVB | Provention Bio, Inc. | 1436.6% | 1408.1% |
TGTX | TG Therapeutics, Inc. | 1105.2% | 176298.9% |
ALVO | Alvotech | 605.4% | -6.6% |
BNTX | BioNTech SE | 437.3% | -74.1% |
MRNA | Moderna, Inc. | 416% | -43.1% |
AXNX | Axonics, Inc. | 255.8% | 32.3% |
BBIO | BridgeBio Pharma, Inc. | 184.6% | 1110.4% |
ALNY | Alnylam Pharmaceuticals, Inc. | 168.1% | 184% |
IBRX | ImmunityBio, Inc. | 146.8% | -30.5% |
IMGN | ImmunoGen, Inc. | 122.5% | 487.2% |
ACLX | Arcellx, Inc. | 109.2% | 轉虧為盈% |
ITCI | Intra-Cellular Therapies, Inc. | 105.7% | 75.1% |
HCM | HUTCHMED (China) Limited | 59.8% | 243.9% |
OLK | Olink Holding AB (publ) | 49.8% | 39% |
ARGX | argenx SE | 41.6% | 139% |
SRPT | Sarepta Therapeutics, Inc. | 35.1% | 44.1% |
ARWR | Arrowhead Pharmaceuticals, Inc. | 33% | -49% |
GMED | Globus Medical, Inc. | 31.2% | 51% |
MYOV | Myovant Sciences Ltd. | 31.1% | 84.1% |
AXSM | Axsome Therapeutics, Inc. | 27.6% | 243.1% |
SDGR | Schrödinger, Inc. | 26.9% | 15.1% |
GMAB | Genmab A/S | 24.8% | 16.1% |
AMPH | Amphastar Pharmaceuticals, Inc. | 23.2% | 50.3% |
AGL | agilon health, inc. | 20.2% | 75% |
IMCR | Immunocore Holdings plc | 20.2% | 25% |
OSH | Oak Street Health, Inc. | 19.8% | 46.4% |
PACB | Pacific Biosciences of California, Inc. | 16.8% | 72.4% |
TMDX | TransMedics Group, Inc. | 16.2% | 158.7% |
LLY | Eli Lilly and Company | 16% | 36.8% |
AZTA | Azenta, Inc. | 16% | 25.3% |
SHC | Sotera Health Company | 13.7% | 5.8% |
EVO | Evotec SE | 12.4% | 14% |
EVH | Evolent Health, Inc. | 11.9% | 44.9% |
CTLT | Catalent, Inc. | 11.7% | -3.9% |
MASI | Masimo Corporation | 11% | -12.8% |
REGN | Regeneron Pharmaceuticals, Inc. | 10.2% | 14.5% |
BGNE | BeiGene, Ltd. | 9.7% | 101.6% |
NVO | Novo Nordisk A/S | 8.8% | 28.9% |
DXCM | DexCom, Inc. | 8.1% | 26.7% |
HALO | Halozyme Therapeutics, Inc. | 6.9% | 3.4% |
SNY | Sanofi | 6.7% | -3.3% |
MEDP | Medpace Holdings, Inc. | 6.6% | 28.3% |
ITGR | Integer Holdings Corporation | 6.6% | 18.1% |
CI | Cigna Corporation | 5.5% | 8.5% |
ICUI | ICU Medical, Inc. | 5.5% | -7.5% |
CORT | Corcept Therapeutics Incorporated | 5.3% | 21.5% |
PFE | Pfizer Inc. | 5.3% | -41.5% |
GH | Guardant Health, Inc. | 5% | 21.8% |
GILD | Gilead Sciences, Inc. | 4.8% | 0.1% |
BRKR | Bruker Corporation | 4.6% | 16.3% |
MOH | Molina Healthcare, Inc. | 4.3% | 7.8% |
EHC | Encompass Health Corporation | 4.3% | 10.8% |
WST | West Pharmaceutical Services, Inc. | 4.3% | 8.8% |
PODD | Insulet Corporation | 4% | 27% |
NEO | NeoGenomics, Inc. | 3.8% | 18% |
BMRN | BioMarin Pharmaceutical Inc. | 3.8% | 15% |
SYNH | Syneos Health, Inc. | 3.8% | 0.4% |
VEEV | Veeva Systems Inc. | 3.7% | 11.6% |
CNC | Centene Corporation | 3.7% | 6.1% |
MDT | Medtronic plc | 3.4% | 5.3% |
BAX | Baxter International Inc. | 3.3% | -1.7% |
BIIB | Biogen Inc. | 3.3% | 0.9% |
TAK | Takeda Pharmaceutical Company Limited | 3% | 4.1% |
GSK | GSK plc | 2.9% | 4.1% |
HQY | HealthEquity, Inc. | 2.9% | 15.3% |
WBA | Walgreens Boots Alliance, Inc. | 2.8% | 9.2% |
JAZZ | Jazz Pharmaceuticals plc | 2.8% | 3.3% |
DVA | DaVita Inc. | 2.7% | 5.9% |
COO | The Cooper Companies, Inc. | 2.6% | 10.3% |
UHS | Universal Health Services, Inc. | 2.5% | 6.8% |
CAH | Cardinal Health, Inc. | 2.4% | 10.4% |
ABT | Abbott Laboratories | 2.3% | -2.6% |
CHE | Chemed Corporation | 2.2% | 7.2% |
TFX | Teleflex Incorporated | 2.1% | 8.7% |
MCK | McKesson Corporation | 2.1% | 10.1% |
BDX | Becton, Dickinson and Company | 1.9% | 6.8% |
FMS | Fresenius Medical Care AG & Co. KGaA | 1.9% | -3.1% |
CVS | CVS Health Corporation | 1.8% | 10.6% |
DOCS | Doximity, Inc. | 1.7% | 11.2% |
HUM | Humana Inc. | 1.6% | 15.9% |
ABC | AmerisourceBergen Corporation | 1.6% | 12.7% |
COR | Cencora | 1.6% | 12.7% |
ATR | AptarGroup, Inc. | 1.6% | 6.7% |
MMSI | Merit Medical Systems, Inc. | 1.6% | 9.8% |
IQV | IQVIA Holdings Inc. | 1.5% | 4.9% |
ELAN | Elanco Animal Health Incorporated | 1.5% | 3.9% |
HLN | Haleon plc | 1.3% | -3.3% |
MRK | Merck & Co., Inc. | 1.3% | 6.7% |
NARI | Inari Medical, Inc. | 1.3% | 31.4% |
HCA | HCA Healthcare, Inc. | 1.2% | 8.3% |
RVTY | Revvity, Inc. | 1.2% | -5.8% |
BMY | Bristol-Myers Squibb Company | 1.1% | -2.2% |
UNH | UnitedHealth Group Incorporated | 1.1% | 14.9% |
SGRY | Surgery Partners, Inc. | 1% | 8.6% |
TMO | Thermo Fisher Scientific Inc. | 1% | -1% |
NUVA | NuVasive, Inc. | 1% | 2.4% |
BPMC | Blueprint Medicines Corporation | 1% | -14.3% |
ACHC | Acadia Healthcare Company, Inc. | 0.9% | 12.5% |
LIVN | LivaNova PLC | 0.8% | 13.3% |
DHR | Danaher Corporation | 0.8% | -10.3% |
LNTH | Lantheus Holdings, Inc. | 0.8% | 33.7% |
AMED | Amedisys, Inc. | 0.8% | -0.3% |
PRVA | Privia Health Group, Inc. | 0.7% | 21.7% |
UTHR | United Therapeutics Corporation | 0.7% | 18.1% |
ZLAB | Zai Lab Limited | 0.7% | 20.3% |
IDXX | IDEXX Laboratories, Inc. | 0.7% | 8.8% |
NTRA | Natera, Inc. | 0.6% | 27.4% |
PEN | Penumbra, Inc. | 0.6% | 26.8% |
ENSG | The Ensign Group, Inc. | 0.6% | 22.2% |
LEGN | Legend Biotech Corporation | 0.6% | 250.9% |
SWAV | ShockWave Medical, Inc. | 0.4% | 41.6% |
PINC | Premier, Inc. | 0.1% | 1.6% |
PBH | Prestige Consumer Healthcare Inc. | - | -1% |
SNN | Smith & Nephew plc | - | 5.2% |
IART | Integra LifeSciences Holdings Corporation | -0.1% | -0.7% |
PKI | PerkinElmer, Inc. | -0.2% | -42.3% |
CRL | Charles River Laboratories International, Inc. | -0.2% | 3.8% |
SEM | Select Medical Holdings Corporation | -0.3% | 6.2% |
LFST | LifeStance Health Group, Inc. | -0.4% | 20.8% |
PGNY | Progyny, Inc. | -0.4% | 36.8% |
IRTC | iRhythm Technologies, Inc. | -0.6% | 20% |
BHC | Bausch Health Companies Inc. | -0.6% | 9.4% |
ABCM | Abcam plc | -0.7% | 9.7% |
FOLD | Amicus Therapeutics, Inc. | -0.8% | 26.7% |
TDOC | Teladoc Health, Inc. | -1% | 8% |
ABBV | AbbVie Inc. | -1% | -6% |
STE | STERIS plc | -1% | 11.8% |
PRGO | Perrigo Company plc | -1.1% | 2.1% |
AMGN | Amgen Inc. | -1.1% | 3.8% |
EXEL | Exelixis, Inc. | -1.2% | 14.6% |
TEVA | Teva Pharmaceutical Industries Limited | -1.3% | 7.1% |
EW | Edwards Lifesciences Corporation | -1.4% | 12.3% |
LH | Laboratory Corporation of America Holdings | -1.5% | -15.2% |
ISRG | Intuitive Surgical, Inc. | -1.7% | 12% |
ELV | Elevance Health Inc. | -1.9% | 7.3% |
SYK | Stryker Corporation | -1.9% | 9.6% |
BSX | Boston Scientific Corporation | -2.1% | 11.3% |
PHG | Koninklijke Philips N.V. | -2.2% | 3.7% |
THC | Tenet Healthcare Corporation | -2.4% | 5.5% |
LHCG | LHC Group, Inc. | -2.5% | -4.3% |
ABMD | Abiomed, Inc. | -2.5% | 7.2% |
PDCO | Patterson Companies, Inc. | -2.7% | 1.6% |
HAE | Haemonetics Corporation | -2.8% | 7% |
BLCO | Bausch + Lomb Corporation | -2.9% | 6.9% |
RDNT | RadNet, Inc. | -2.9% | 14.8% |
WAT | Waters Corporation | -3.2% | 0.4% |
VTRS | Viatris Inc. | -3.5% | -3.3% |
OGN | Organon & Co. | -3.7% | -1.2% |
CNMD | CONMED Corporation | -3.7% | 10.7% |
CERT | Certara, Inc. | -3.7% | 1% |
RPRX | Royalty Pharma plc | -3.8% | -6.5% |
ZTS | Zoetis Inc. | -3.9% | 7.4% |
HSIC | Henry Schein, Inc. | -4% | 3.1% |
EXAS | Exact Sciences Corporation | -4.1% | 20.1% |
AZN | AstraZeneca PLC | -4.1% | 4.6% |
TECH | Bio-Techne Corporation | -4.3% | 2.7% |
ICLR | ICON Public Limited Company | -4.5% | 5.8% |
BEAM | Beam Therapeutics Inc. | -4.7% | 8.8% |
OPCH | Option Care Health, Inc. | -5% | 7.1% |
RGEN | Repligen Corporation | -5% | -29.7% |
A | Agilent Technologies, Inc. | -5.3% | -8.7% |
GKOS | Glaukos Corporation | -5.5% | 9.5% |
DGX | Quest Diagnostics Incorporated | -5.9% | -7.7% |
VRTX | Vertex Pharmaceuticals Incorporated | -6.2% | 6.4% |
RDY | Dr. Reddy's Laboratories Limited | -6.5% | 9.1% |
ILMN | Illumina, Inc. | -6.7% | 0.4% |
ALGN | Align Technology, Inc. | -6.9% | 7.8% |
TXG | 10x Genomics, Inc. | -7.1% | 17.2% |
ONEM | 1Life Healthcare, Inc. | -7.2% | 20% |
MTD | Mettler-Toledo International Inc. | -7.4% | -4.4% |
BIO | Bio-Rad Laboratories, Inc. | -7.5% | -7.1% |
XRAY | DENTSPLY SIRONA Inc. | -7.5% | - |
RMD | ResMed Inc. | -7.7% | 1.3% |
INCY | Incyte Corporation | -7.8% | 11.6% |
ACAD | ACADIA Pharmaceuticals Inc. | -8.3% | 62% |
AMN | AMN Healthcare Services, Inc. | -8.6% | -25% |
ZBH | Zimmer Biomet Holdings, Inc. | -8.9% | 5% |
HOLX | Hologic, Inc. | -8.9% | -0.8% |
HZNP | Horizon Therapeutics Public Limited Company | -9% | 7.8% |
NVST | Envista Holdings Corporation | -9.1% | - |
NBIX | Neurocrine Biosciences, Inc. | -9.5% | 28.6% |
SGEN | Seagen Inc. | -9.8% | 27.1% |
ALC | Alcon Inc. | -10% | 8.8% |
KDNY | Chinook Therapeutics, Inc. | -10.7% | 141.1% |
GRFS | Grifols, S.A. | -11.6% | 3.5% |
NVS | Novartis AG | -12% | -5.8% |
DNA | Ginkgo Bioworks Holdings, Inc. | -12.3% | -16.5% |
INSM | Insmed Incorporated | -12.8% | 16.7% |
RCM | R1 RCM Inc. | -13.5% | 15.5% |
RXDX | Prometheus Biosciences, Inc. | -13.5% | -71.8% |
ROIV | Roivant Sciences Ltd. | -13.8% | 196% |
INSP | Inspire Medical Systems, Inc. | -14% | 40.4% |
NTLA | Intellia Therapeutics, Inc. | -14.7% | -9.6% |
JNJ | Johnson & Johnson | -15.9% | -10.3% |
QDEL | QuidelOrtho Corporation | -16.3% | -5.1% |
INMD | InMode Ltd. | -17.2% | 1.6% |
ASND | Ascendis Pharma A/S | -21% | 214.2% |
IONS | Ionis Pharmaceuticals, Inc. | -23.1% | -9.9% |
SGFY | Signify Health, Inc. | -24.4% | 11.9% |
RARE | Ultragenyx Pharmaceutical Inc. | -31.7% | 8.1% |
GLPG | Galapagos NV | -33.7% | -11.9% |
ALKS | Alkermes plc | -34.2% | 51% |
MRTX | Mirati Therapeutics, Inc. | -43.2% | 202% |
APLS | Apellis Pharmaceuticals, Inc. | -45.8% | 349.7% |
CYTK | Cytokinetics, Incorporated | -72% | -85% |
CRNX | Crinetics Pharmaceuticals, Inc. | -85.7% | -24.5% |
DNLI | Denali Therapeutics Inc. | -99.6% | -64.4% |
CBAY | CymaBay Therapeutics, Inc. | -100% | - |
CRSP | CRISPR Therapeutics AG | -100% | -100% |
RVMD | Revolution Medicines, Inc. | -100% | -100% |
BHVN | Biohaven Pharmaceutical Holding Company Ltd. | - | - |
CERE | Cerevel Therapeutics Holdings, Inc. | - | - |
DICE | DICE Therapeutics, Inc. | - | - |
IMVT | Immunovant, Inc. | - | - |
ISEE | IVERIC bio, Inc. | - | - |
IXHL | Incannex Healthcare Limited | - | -100% |
KRTX | Karuna Therapeutics, Inc. | - | -100% |
MDGL | Madrigal Pharmaceuticals, Inc. | - | - |
MLTX | MoonLake Immunotherapeutics | - | - |
NUVL | Nuvalent, Inc. | - | - |
PCVX | Vaxcyte, Inc. | - | - |
RCKT | Rocket Pharmaceuticals, Inc. | - | - |
XENE | Xenon Pharmaceuticals Inc. | - | -100% |
FTRE | Fortrea Holdings Inc. | - | - |
GEHC | GE HealthCare Technologies Inc. | - | - |
GPCR | Structure Therapeutics Inc. | - | - |
